ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Keytruda approved for second blood cancer
pharmatimes
June 21, 2018US regulators have again expanded the list of approved uses of MSD’s immunotherapy Keytruda, issuing a green light for the treatment of primary mediastinal large B-cell lymphoma (PMBCL).
Pharma Sources Insight January 2025
